ZWJ Investment Counsel Inc. raised its stake in Anthem Inc (NYSE:ANTM) by 6.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 121,839 shares of the company’s stock after buying an additional 7,736 shares during the quarter. Anthem accounts for about 2.7% of ZWJ Investment Counsel Inc.’s portfolio, making the stock its 5th largest position. ZWJ Investment Counsel Inc.’s holdings in Anthem were worth $34,384,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors also recently added to or reduced their stakes in the business. Greenleaf Trust raised its position in shares of Anthem by 1.3% during the second quarter. Greenleaf Trust now owns 6,044 shares of the company’s stock worth $1,706,000 after purchasing an additional 79 shares during the period. Logan Capital Management Inc. raised its position in shares of Anthem by 9.1% during the second quarter. Logan Capital Management Inc. now owns 6,502 shares of the company’s stock worth $1,835,000 after purchasing an additional 545 shares during the period. James Investment Research Inc. raised its position in shares of Anthem by 13.0% during the second quarter. James Investment Research Inc. now owns 73,121 shares of the company’s stock worth $20,635,000 after purchasing an additional 8,422 shares during the period. Daiwa Securities Group Inc. raised its position in shares of Anthem by 3.5% during the second quarter. Daiwa Securities Group Inc. now owns 13,415 shares of the company’s stock worth $3,786,000 after purchasing an additional 455 shares during the period. Finally, Convergence Investment Partners LLC raised its position in shares of Anthem by 4.2% during the second quarter. Convergence Investment Partners LLC now owns 943 shares of the company’s stock worth $266,000 after purchasing an additional 38 shares during the period. 87.38% of the stock is currently owned by hedge funds and other institutional investors.
Anthem stock traded down $2.38 during midday trading on Friday, reaching $290.57. The stock had a trading volume of 909,537 shares, compared to its average volume of 1,402,589. The company’s fifty day moving average is $292.70. Anthem Inc has a 1-year low of $227.16 and a 1-year high of $317.99. The stock has a market capitalization of $74.94 billion, a PE ratio of 18.29, a P/E/G ratio of 1.08 and a beta of 0.71. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.57.
Anthem (NYSE:ANTM) last announced its earnings results on Wednesday, July 24th. The company reported $4.64 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $4.61 by $0.03. The business had revenue of $25.20 billion for the quarter, compared to analyst estimates of $24.88 billion. Anthem had a return on equity of 15.02% and a net margin of 4.21%. Anthem’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same quarter last year, the firm earned $4.25 EPS. As a group, equities analysts anticipate that Anthem Inc will post 19.35 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be paid a $0.80 dividend. The ex-dividend date is Monday, September 9th. This represents a $3.20 dividend on an annualized basis and a yield of 1.10%. Anthem’s dividend payout ratio is 20.14%.
A number of research firms have recently commented on ANTM. Cantor Fitzgerald reaffirmed a “buy” rating and set a $360.00 price target on shares of Anthem in a research report on Sunday, April 21st. Zacks Investment Research raised Anthem from a “hold” rating to a “buy” rating and set a $293.00 price target on the stock in a research report on Thursday, May 16th. SunTrust Banks dropped their price target on Anthem to $300.00 and set a “hold” rating on the stock in a research report on Thursday, April 25th. Barclays lifted their target price on Anthem from $316.00 to $317.00 and gave the company an “overweight” rating in a research report on Thursday, April 25th. Finally, UBS Group initiated coverage on Anthem in a research report on Tuesday, April 23rd. They issued a “buy” rating and a $294.00 target price on the stock. Two analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $325.67.
In other Anthem news, Director Robert L. Dixon, Jr. sold 520 shares of the firm’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $294.11, for a total value of $152,937.20. Following the completion of the transaction, the director now directly owns 9,971 shares in the company, valued at $2,932,570.81. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Ronald W. Penczek sold 763 shares of the firm’s stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $279.00, for a total value of $212,877.00. Following the completion of the transaction, the senior vice president now owns 2,295 shares of the company’s stock, valued at $640,305. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 11,765 shares of company stock valued at $3,327,092. Corporate insiders own 0.17% of the company’s stock.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Recommended Story: Book Value Per Share – BVPS
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.